UM

Browse/Search Results:  1-10 of 23 Help

Selected(0)Clear Items/Page:    Sort:
Supramolecular systems for bioapplications: recent research progress in China Journal article
Liu, Yue Yang, Yu, Xiao Yong, Pan, Yu Chen, Yin, Hang, Chao, Shuang, Li, Yujie, Ma, He, Zuo, Minzan, Teng, Kun Xu, Hou, Jun Li, Chen, Yong, Guo, Dong Sheng, Wang, Ruibing, Pei, Yuxin, Pei, Zhichao, Xu, Jiang Fei, Hu, Xiao Yu, Li, Chunju, Yang, Qing Zheng, Wang, Leyong, Liu, Yu, Li, Zhan Ting. Supramolecular systems for bioapplications: recent research progress in China[J]. Science China Chemistry, 2024, 67(5), 1397-1441.
Authors:  Liu, Yue Yang;  Yu, Xiao Yong;  Pan, Yu Chen;  Yin, Hang;  Chao, Shuang; et al.
Favorite | TC[WOS]:12 TC[Scopus]:13  IF:10.4/7.9 | Submit date:2024/05/16
Anticancer And Antibacterial  Antidote  Bioimaging And Biosensing  Drug Delivery  Host-guest Chemistry  Photodynamic Therapy  Photothermal Therapy  Transmembrane Channel  
Characteristics of clinical trials of new oncology drugs approved in China Journal article
Yang, Jing, Yang, Ji, Hu, Yuan Jia. Characteristics of clinical trials of new oncology drugs approved in China[J]. Cancer, 2024, 130(5), 671-682.
Authors:  Yang, Jing;  Yang, Ji;  Hu, Yuan Jia
Favorite | TC[WOS]:3 TC[Scopus]:2  IF:6.1/6.7 | Submit date:2024/05/16
Clinical Evidence  Drug Lag  Novel Anticancer Drugs  Pivotal Clinical Trials  Programmed Death-1 (Pd-1) Inhibitors  Programmed Death-ligand 1 (Pd-l1) Inhibitors  
Characteristics of clinical trials of new oncology drugs approved in China Review article
2023
Authors:  Jing Yang;  Ji Yang;  HU YUANJIA
Adobe PDF | Favorite | TC[WOS]:3 TC[Scopus]:2  IF:6.1/6.7 | Submit date:2024/01/02
Clinical Evidence  Drug Lag  Novel Anticancer Drugs  Pivotal Clinical Trials  Programmed Death-1 (Pd-1) Inhibitors  Programmed Death-ligand 1 (Pd-l1) Inhibitors  
Polysaccharide-Based Stimulus-Responsive Nanomedicines for Combination Cancer Immunotherapy Journal article
Li, Qiuxia, Liu, Xing, Yan, Chunmei, Zhao, Bolin, Zhao, Yuxin, Yang, Lu, Shi, Mingyi, Yu, Hua, Li, Xiaofang, Luo, Kaipei. Polysaccharide-Based Stimulus-Responsive Nanomedicines for Combination Cancer Immunotherapy[J]. Small, 2023, 19(23), 2206211.
Authors:  Li, Qiuxia;  Liu, Xing;  Yan, Chunmei;  Zhao, Bolin;  Zhao, Yuxin; et al.
Favorite | TC[WOS]:27 TC[Scopus]:29  IF:13.0/13.5 | Submit date:2023/07/20
Anticancer Efficacy  Combination Cancer Immunotherapy  Drug Delivery  Polysaccharide  Stimulus-responsive Nanomedicines  
Recent advances in organotypic tissue slice cultures for anticancer drug development Review article
2022
Authors:  He, Lin;  Deng, Chuxia
Favorite | TC[WOS]:16 TC[Scopus]:17  IF:8.2/8.3 | Submit date:2023/01/30
Anticancer Drug Discovery  Individualized Treatment  Organotypic Tissue Slice Culture  Precision Oncology  
Synthesis of hydrogels based on nanocellulose from garlic straw and regulating the release of allicin and its cytotoxicity Journal article
Gao, Xudong, Jia, Yanan, Chen, Zhongqin, Santhanam, Ramesh Kumar, Zhang, Min, He, Chengwei, Chen, Haixia. Synthesis of hydrogels based on nanocellulose from garlic straw and regulating the release of allicin and its cytotoxicity[J]. Food Science and Technology, 2022, 42, e43422.
Authors:  Gao, Xudong;  Jia, Yanan;  Chen, Zhongqin;  Santhanam, Ramesh Kumar;  Zhang, Min; et al.
Favorite | TC[WOS]:5 TC[Scopus]:4  IF:2.602/2.968 | Submit date:2022/08/05
Allicin  Anticancer  Drug Release  Garlic Straw  Hydrogels  
Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview Review article
2021
Authors:  Kumar, Pradeep;  Mahato, Dipendra Kumar;  Kamle, Madhu;  Borah, Rituraj;  Sharma, Bharti; et al.
Favorite | TC[WOS]:50 TC[Scopus]:54  IF:6.1/7.0 | Submit date:2021/12/08
Anticancer  C. Sativa  Cannabinoids  Ethnopharmacological Properties  Legalization  Psychoactive Drug  Public Health  
Chitosan-based nanoscale and non-nanoscale delivery systems for anticancer drugs: A review Review article
2021
Authors:  Tian, Bingren;  Liu, Yumei;  Liu, Jiayue
Favorite | TC[WOS]:30 TC[Scopus]:39  IF:5.8/5.3 | Submit date:2021/12/08
Anticancer Drug  Chitosan  Drug Carrier  Potential Application  Sustained-release  
In Vitro and MD Simulation Study to Explore Physicochemical Parameters for Antibacterial Peptide to Become Potent Anticancer Peptide Journal article
Ma,Rui, Wong,Sin Wa, Ge,Lilin, Shaw,Chris, Siu,Shirley W.I., Kwok,Hang Fai. In Vitro and MD Simulation Study to Explore Physicochemical Parameters for Antibacterial Peptide to Become Potent Anticancer Peptide[J]. Molecular Therapy-Oncolytics, 2020, 16, 7-19.
Authors:  Ma,Rui;  Wong,Sin Wa;  Ge,Lilin;  Shaw,Chris;  Siu,Shirley W.I.; et al.
Favorite | TC[WOS]:47 TC[Scopus]:47  IF:5.3/5.2 | Submit date:2021/03/04
Angiogenesis  Anticancer Peptides  Antimicrobial Peptides  Apoptosis  Drug Discovery And Development  Molecular Dynamics  Targeted Therapy  
LFB: A novel antimicrobial Brevinin-like peptide from the skin secretion of the Fujian large headed frog, Limnonectes fujianensi Journal article
Li, B., Lyu, P., Xie, S., Qin, H., Pu, W., Xu, H., Chen, T., Shaw, C., Ge, L., Kwok, H. F.. LFB: A novel antimicrobial Brevinin-like peptide from the skin secretion of the Fujian large headed frog, Limnonectes fujianensi[J]. Biomolecules, 2019, 242---.
Authors:  Li, B.;  Lyu, P.;  Xie, S.;  Qin, H.;  Pu, W.; et al.
Favorite |   IF:4.8/5.4 | Submit date:2022/06/02
Amphibian  Brevinin-like Peptide  Antimicrobial Peptides  Anticancer Peptide  Drug Discovery